Sandoz shares plunged Wednesday on their market debut after the generic and biosimilar drugmaker’s value was measured at a lower-than-expected 10.3 billion Swiss francs ($11.2
Latest News & Today Headlines from Turkey, World, Entertainment, Business, Sports, Health, science, technology, etc. All News in one place.